254 related articles for article (PubMed ID: 1380402)
21. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
Verdoorn TA; Dingledine R
Mol Pharmacol; 1988 Sep; 34(3):298-307. PubMed ID: 2901662
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of neuroprotection against NMDA-induced brain injury.
McDonald JW; Roeser NF; Silverstein FS; Johnston MV
Exp Neurol; 1989 Dec; 106(3):289-96. PubMed ID: 2687017
[TBL] [Abstract][Full Text] [Related]
23. Quisqualate neurotoxicity in rat cortical cultures: pharmacology and mechanisms.
Zinkand WC; DeFeo PA; Thompson C; Hargrove H; Salama AI; Patel J
Eur J Pharmacol; 1992 Mar; 212(2-3):129-36. PubMed ID: 1534767
[TBL] [Abstract][Full Text] [Related]
24. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR
J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114
[TBL] [Abstract][Full Text] [Related]
25. Selective alterations in glutamate receptor subtypes after unilateral orbital enucleation.
Chalmers DT; McCulloch J
Brain Res; 1991 Feb; 540(1-2):255-65. PubMed ID: 1647245
[TBL] [Abstract][Full Text] [Related]
26. Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons.
Marin P; Quignard JF; Lafon-Cazal M; Bockaert J
Neuropharmacology; 1993 Jan; 32(1):29-36. PubMed ID: 8094233
[TBL] [Abstract][Full Text] [Related]
27. Quisqualate receptors in epileptic fowl: the absence of coupling between quisqualate and N-methyl-D-aspartate receptors.
Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
Eur J Pharmacol; 1990 Jan; 175(1):85-91. PubMed ID: 2157599
[TBL] [Abstract][Full Text] [Related]
28. Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate.
Greene JG; Greenamyre JT
J Neurochem; 1995 May; 64(5):2332-8. PubMed ID: 7536810
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
Foster AC; Gill R; Woodruff GN
J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
[TBL] [Abstract][Full Text] [Related]
30. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
Curras MC; Dingledine R
Mol Pharmacol; 1992 Mar; 41(3):520-6. PubMed ID: 1372086
[TBL] [Abstract][Full Text] [Related]
31. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
[TBL] [Abstract][Full Text] [Related]
32. AMPA, kainate, and quisqualate activate a common receptor-channel complex on embryonic chick motoneurons.
Zorumski CF; Yang J
J Neurosci; 1988 Nov; 8(11):4277-86. PubMed ID: 2460595
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids.
Turski L; Niemann W; Stephens DN
Neuroscience; 1990; 39(3):799-807. PubMed ID: 2097526
[TBL] [Abstract][Full Text] [Related]
34. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.
McDonald JW; Silverstein FS; Johnston MV
Neuroscience; 1990; 38(1):103-13. PubMed ID: 2255390
[TBL] [Abstract][Full Text] [Related]
35. The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury.
McDonald JW; Schoepp DD
Eur J Pharmacol; 1992 May; 215(2-3):353-4. PubMed ID: 1383003
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
37. Electrogenic uptake contributes a major component of the depolarizing action of L-glutamate in rat hippocampal slices.
Frenguelli BG; Blake JF; Brown MW; Collingridge GL
Br J Pharmacol; 1991 Feb; 102(2):355-62. PubMed ID: 1673070
[TBL] [Abstract][Full Text] [Related]
38. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.
Cha JH; Makowiec RL; Penney JB; Young AB
Mol Pharmacol; 1992 May; 41(5):832-8. PubMed ID: 1375315
[TBL] [Abstract][Full Text] [Related]
39. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Ruzicka BB; Jhamandas K
Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
[TBL] [Abstract][Full Text] [Related]
40. Delayed postnatal development of NMDA receptor function in medium-sized neurons of the rat striatum.
Hurst RS; Cepeda C; Shumate LW; Levine MS
Dev Neurosci; 2001; 23(2):122-34. PubMed ID: 11509835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
